Zacks Investment Research
30 Sept 2026, 22:50 UTC · 1h ago
Viking Therapeutics, Inc. (VKTX) Rises As Market Takes a Dip: Key Facts
Verdict
Headline leans bullish. We score VKTX +0.20 across three claims.
Score confirms the headline.
- Headline says
Leans bullish
From its wording — no explicit rating
- Expected · VKTX
+0.20slightly bullish